SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Susanne A. Schneider, Movement Disorders, 2015,

    CrossRef

  2. 2
    G. M. Pocas, J. Branco-Santos, F. Herrera, T. F. Outeiro, P. M. Domingos,  -Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila, Human Molecular Genetics, 2014,

    CrossRef

  3. 3
    Simon Moussaud, Daryl R Jones, Elisabeth L Moussaud-Lamodière, Marion Delenclos, Owen A Ross, Pamela J McLean, Alpha-synuclein and tau: teammates in neurodegeneration?, Molecular Neurodegeneration, 2014, 9, 1, 43

    CrossRef

  4. 4
    Jing L Guo, Virginia M Y Lee, Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases, Nature Medicine, 2014, 20, 2, 130

    CrossRef

  5. 5
    Campbell J Le Heron, Sarah L Wright, Tracy R Melzer, Daniel J Myall, Michael R MacAskill, Leslie Livingston, Ross J Keenan, Richard Watts, John C Dalrymple-Alford, Tim J Anderson, Comparing cerebral perfusion in Alzheimer’s disease and Parkinson’s disease dementia: an ASL-MRI study, Journal of Cerebral Blood Flow & Metabolism, 2014, 34, 6, 964

    CrossRef

  6. 6
    Satoshi Yamashita, Naomi Sakashita, Taro Yamashita, Nozomu Tawara, Masayoshi Tasaki, Kensuke Kawakami, Yoshihiro Komohara, Yukio Fujiwara, Masashi Kamikawa, Takenobu Nakagawa, Teruyuki Hirano, Yasushi Maeda, Masato Hasegawa, Motohiro Takeya, Yukio Ando, Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration, Journal of Neurology, 2014, 261, 11, 2209

    CrossRef

  7. 7
    Marta Swirski, J Miners, Rohan de Silva, Tammaryn Lashley, Helen Ling, Janice Holton, Tamas Revesz, Seth Love, Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease, Alzheimer's Research & Therapy, 2014, 6, 5-8, 77

    CrossRef

  8. 8
    B I Pérez-Revuelta, M M Hettich, A Ciociaro, C Rotermund, P J Kahle, S Krauss, D A Di Monte, Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation, Cell Death and Disease, 2014, 5, 5, e1209

    CrossRef

  9. 9
    Gabrielle R. Wilson, Joe C.H. Sim, Catriona McLean, Maila Giannandrea, Charles A. Galea, Jessica R. Riseley, Sarah E.M. Stephenson, Elizabeth Fitzpatrick, Stefan A. Haas, Kate Pope, Kirk J. Hogan, Ronald G. Gregg, Catherine J. Bromhead, David S. Wargowski, Christopher H. Lawrence, Paul A. James, Andrew Churchyard, Yujing Gao, Dean G. Phelan, Greta Gillies, Nicholas Salce, Lynn Stanford, Ashley P.L. Marsh, Maria L. Mignogna, Susan J. Hayflick, Richard J. Leventer, Martin B. Delatycki, George D. Mellick, Vera M. Kalscheuer, Patrizia D’Adamo, Melanie Bahlo, David J. Amor, Paul J. Lockhart, Mutations in RAB39B Cause X-Linked Intellectual Disability and Early-Onset Parkinson Disease with α-Synuclein Pathology, The American Journal of Human Genetics, 2014, 95, 6, 729

    CrossRef

  10. 10
    Gaia Grassetto, Maria Cristina Marzola, Alessandra Musto, Sobhan Viniamury, Patrick M. Colletti, Alan C. Perkins, Domenico Rubello, Non-Alzheimer types of neurodegenerative dementia, Nuclear Medicine Communications, 2014, 35, 11, 1085

    CrossRef

  11. 11
    Katharina Pukaß, Christiane Richter-Landsberg, Oxidative Stress Promotes Uptake, Accumulation, and Oligomerization of Extracellular α-Synuclein in Oligodendrocytes, Journal of Molecular Neuroscience, 2014, 52, 3, 339

    CrossRef

  12. 12
    Sreedevi Chandrasekaran, Danail Bonchev, A NETWORK VIEW ON PARKINSON'S DISEASE, Computational and Structural Biotechnology Journal, 2013, 7, 8, 1

    CrossRef

  13. 13
    Martí Colom-Cadena, Ellen Gelpi, Sara Charif, Olivia Belbin, Rafael Blesa, Maria J. Martí, Jordi Clarimón, Alberto Lleó, Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies, Journal of Neuropathology & Experimental Neurology, 2013, 72, 12, 1203

    CrossRef

  14. 14
    Jing L. Guo, Dustin J. Covell, Joshua P. Daniels, Michiyo Iba, Anna Stieber, Bin Zhang, Dawn M. Riddle, Linda K. Kwong, Yan Xu, John Q. Trojanowski, Virginia M.Y. Lee, Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons, Cell, 2013, 154, 1, 103

    CrossRef

  15. 15
    Mithilesh Kumar Jha, Kyoungho Suk, Glia-based biomarkers and their functional role in the CNS, Expert Review of Proteomics, 2013, 10, 1, 43

    CrossRef

  16. 16
    Christiane Richter-Landsberg, Janina Leyk, Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration, Acta Neuropathologica, 2013, 126, 6, 793

    CrossRef

  17. 17
    Kateřina Menšíková, Radoslav Matěj, Lucie Tučková, Robert Rusina, Jiří Ehrmann, Petr Kaňovský, Progressive supranuclear palsy phenotype mimicking synucleinopathies, Journal of the Neurological Sciences, 2013, 329, 1-2, 34

    CrossRef

  18. 18
    Michael A. Castello, Salvador Soriano, Rational heterodoxy: Cholesterol reformation of the amyloid doctrine, Ageing Research Reviews, 2013, 12, 1, 282

    CrossRef

  19. 19
    Myria Petrou, Vikas Kotagal, Nicolaas I Bohnen, An update on brain imaging in parkinsonian dementia, Imaging in Medicine, 2012, 4, 2, 201

    CrossRef

  20. 20
    Alessandro Stefani, Livia Brusa, Enrica Olivola, Mariangela Pierantozzi, Alessandro Martorana, CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD, Journal of Neural Transmission, 2012, 119, 7, 861

    CrossRef

  21. 21
    Kurt A. Jellinger, Interaction between pathogenic proteins in neurodegenerative disorders, Journal of Cellular and Molecular Medicine, 2012, 16, 6
  22. 22
    G. Nübling, J. Levin, B. Bader, L. Israel, K. Bötzel, S. Lorenzl, A. Giese, Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation, Experimental Neurology, 2012, 237, 2, 470

    CrossRef

  23. 23
    T. A. Shelkovnikova, A. A. Kulikova, Ph. O. Tsvetkov, O. Peters, S. O. Bachurin, V. L. Buchman, N. N. Ninkina, Proteinopathies, neurodegenerative disorders with protein aggregation-based pathology, Molecular Biology, 2012, 46, 3, 362

    CrossRef

  24. 24
    Fabio Di Domenico, Rukhsana Sultana, Andrew Ferree, Katelyn Smith, Eugenio Barone, Marzia Perluigi, Raffaella Coccia, William Pierce, Jian Cai, Cesare Mancuso, Rachel Squillace, Manfred Wiengele, Isabella Dalle-Donne, Benjamin Wolozin, D. Allan Butterfield, Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau onC. elegansProtein Expression and Oxidative Modification: Relevance to Parkinson Disease, Antioxidants & Redox Signaling, 2012, 17, 11, 1490

    CrossRef

  25. 25
    Markos Poulopoulos, Oren A. Levy, Roy N. Alcalay, The neuropathology of genetic Parkinson's disease, Movement Disorders, 2012, 27, 7
  26. 26
    Kurt A. Jellinger, The role of α-synuclein in neurodegeneration — An update, Translational Neuroscience, 2012, 3, 2, 75

    CrossRef

  27. 27
    Federico Herrera, Tiago Fleming Outeiro, α-Synuclein modifies huntingtin aggregation in living cells, FEBS Letters, 2012, 586, 1, 7

    CrossRef

  28. 28
    Jean Cambier, Maurice Masson, Catherine Masson, † Henri Dehen, Neurologie, 2012,

    CrossRef

  29. 29
    Brit Mollenhauer, Walter J Schulz-Schaeffer, Michael G Schlossmacher, CSF α-synuclein, tau, and amyloid β in Parkinson's disease – Authors' reply, The Lancet Neurology, 2011, 10, 8, 681

    CrossRef

  30. 30
    S. S. Ambegaokar, G. R. Jackson, Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation, Human Molecular Genetics, 2011, 20, 24, 4947

    CrossRef

  31. 31
    Kurt A. Jellinger, Interaction between ��-Synuclein and Other Proteins in Neurodegenerative Disorders, The Scientific World JOURNAL, 2011, 11, 1893

    CrossRef

  32. 32
    C. Echávarri, M.C. Caballero, A. Aramendía, F. García-Bragado, T. Tuñón, Multiprotein Deposits in Neurodegenerative Disorders: Our Experience in the Tissue Brain Bank of Navarra, The Anatomical Record, 2011, 294, 7
  33. 33
    Benedikt Bader, Georg Nübling, Anja Mehle, Simona Nobile, Hans Kretzschmar, Armin Giese, Single particle analysis of tau oligomer formation induced by metal ions and organic solvents, Biochemical and Biophysical Research Communications, 2011, 411, 1, 190

    CrossRef

  34. 34
    C. Wider, C. Vilariño-Güell, M. G. Heckman, B. Jasinska-Myga, A. I. Ortolaza-Soto, N. N. Diehl, J. E. Crook, S. A. Cobb, J. A. Bacon, J. O. Aasly, J. M. Gibson, T. Lynch, R. J. Uitti, Z. K. Wszolek, M. J. Farrer, O. A. Ross, SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study, European Journal of Neurology, 2011, 18, 6
  35. 35
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  36. 36
    Kurt A. Jellinger, Youmans Neurological Surgery, 2011,

    CrossRef

  37. 37
    Gray's Clinical Neuroanatomy: The Anatomic Basis for Clinical Neuroscience, 2011,

    CrossRef

  38. 38
    Georgia Xiromerisiou, Efthimios Dardiotis, Vaïa Tsimourtou, Persa Maria Kountra, Konstantinos N. Paterakis, Eftychia Z. Kapsalaki, Kostas N. Fountas, Georgios M. Hadjigeorgiou, Genetic basis of Parkinson disease, Neurosurgical FOCUS, 2010, 28, 1, E7

    CrossRef

  39. 39
    Dianca R. Graham, Anita Sidhu, Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior, Journal of Neuroscience Research, 2010, 88, 8
  40. 40
    Kathleen Lombard Poston, OVERVIEW OF RARE MOVEMENT DISORDERS, CONTINUUM: Lifelong Learning in Neurology, 2010, 16, 49

    CrossRef

  41. 41
    Kurt A. Jellinger, Peter L. Lantos, Papp–Lantos inclusions and the pathogenesis of multiple system atrophy: an update, Acta Neuropathologica, 2010, 119, 6, 657

    CrossRef

  42. 42
    Vincenzo Bonifati, Shaking the genome: new studies reveal genetic risk for Parkinson's disease, The Lancet Neurology, 2010, 9, 2, 136

    CrossRef

  43. 43
    Lamya S. Shihabuddin, Isabelle Aubert, Stem cell transplantation for neurometabolic and neurodegenerative diseases, Neuropharmacology, 2010, 58, 6, 845

    CrossRef

  44. 44
    Laura K. Teune, Anna L. Bartels, Bauke M. de Jong, Antoon T. M. Willemsen, Silvia A. Eshuis, Jeroen J. de Vries, Joost C. H. van Oostrom, Klaus L. Leenders, Typical cerebral metabolic patterns in neurodegenerative brain diseases, Movement Disorders, 2010, 25, 14
  45. 45
    Christine Klein, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  46. 46
    Caroline M. Tanner, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  47. 47
    Robert J. Phillips, Gary C. Walter, Brittany E. Ringer, Katherine M. Higgs, Terry L. Powley, Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat, Experimental Neurology, 2009, 220, 1, 109

    CrossRef

  48. 48
    Laura Silveira-Moriyama, Ana Marcos González, Sean S. O'Sullivan, David R. Williams, Luke Massey, Laura Parkkinen, Zeshan Ahmed, Rohan de Silva, Jose R. Chacón, Tamas Revesz, Andrew J. Lees, Janice L. Holton, Concomitant progressive supranuclear palsy and multiple system atrophy: More than a simple twist of fate?, Neuroscience Letters, 2009, 467, 3, 208

    CrossRef

  49. 49
    Kurt A. Jellinger, Formation and development of Lewy pathology: a critical update, Journal of Neurology, 2009, 256, S3, 270

    CrossRef

  50. 50
    Kallirhoe Kalinderi, Liana Fidani, Sevasti Bostantjopoulou, From 1997 to 2007: A decade journey through the H1 haplotype on 17q21 chromosome, Parkinsonism & Related Disorders, 2009, 15, 1, 2

    CrossRef

  51. 51
    Inés García-Gorostiaga, Pascual Sánchez-Juan, Ignacio Mateo, Eloy Rodríguez-Rodríguez, Coro Sánchez-Quintana, Soraya Curiel del Olmo, José Luis Vázquez-Higuera, José Berciano, Onofre Combarros, Jon Infante, Glycogen synthase kinase-3β and tau genes interact in Parkinson's and Alzheimer's diseases, Annals of Neurology, 2009, 65, 6
  52. 52
    Christine Klein, Susanne A. Schneider, Anthony E. Lang, Hereditary parkinsonism: Parkinson disease look-alikes—An algorithm for clinicians to “PARK” genes and beyond, Movement Disorders, 2009, 24, 14
  53. 53
    Thomas Gasser, Molecular pathogenesis of Parkinson disease: insights from genetic studies, Expert Reviews in Molecular Medicine, 2009, 11,

    CrossRef

  54. 54
    J. Eric Ahlskog, Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, 10, 721

    CrossRef

  55. 55
    Leslie S. Libow, Pasquale G. Frisina, Vahram Haroutunian, Daniel P. Perl, Dushyant P. Purohit, Parkinson's disease dementia – A diminished role for the Lewy body, Parkinsonism & Related Disorders, 2009, 15, 8, 572

    CrossRef

  56. 56
    S. Lesage, A. Brice, Parkinson's disease: from monogenic forms to genetic susceptibility factors, Human Molecular Genetics, 2009, 18, R1, R48

    CrossRef

  57. 57
    Pier Paolo Peruzzi, Sean E Lawler, Steve L Senior, Nina Dmitrieva, Pauline AH Edser, Davide Gianni, E Antonio Chiocca, Richard Wade-Martins, Physiological Transgene Regulation and Functional Complementation of a Neurological Disease Gene Deficiency in Neurons, Molecular Therapy, 2009, 17, 9, 1517

    CrossRef

  58. 58
    Roberto Vetrugno, Maria Alessandria, Roberto D’Angelo, Giuseppe Plazzi, Federica Provini, Pietro Cortelli, Pasquale Montagna, Status dissociatus evolving from REM sleep behaviour disorder in multiple system atrophy, Sleep Medicine, 2009, 10, 2, 247

    CrossRef

  59. 59
    N. Le Forestier, L. Lacomblez, V. Meininger, Syndromes parkinsoniens et sclérose latérale amyotrophique, Revue Neurologique, 2009, 165, 1, 15

    CrossRef

  60. 60
    C. H. Williams-Gray, J. R. Evans, A. Goris, T. Foltynie, M. Ban, T. W. Robbins, C. Brayne, B. S. Kolachana, D. R. Weinberger, S. J. Sawcer, R. A. Barker, The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort, Brain, 2009, 132, 11, 2958

    CrossRef

  61. 61
    Kurt A. Jellinger, The Neuropathologic Substrate of Parkinson Disease Dementia, Journal of Movement Disorders, 2009, 2, 1, 1

    CrossRef

  62. 62
    John H Pula, Jisoon Kim, Jeffrey Nichols, Visual aspects of neurologic protein misfolding disorders, Current Opinion in Ophthalmology, 2009, 20, 6, 482

    CrossRef

  63. 63
    Michael Riedel, Olaf Goldbaum, Christiane Richter-Landsberg, α-Synuclein Promotes the Recruitment of Tau to Protein Inclusions in Oligodendroglial Cells: Effects of Oxidative and Proteolytic Stress, Journal of Molecular Neuroscience, 2009, 39, 1-2, 226

    CrossRef

  64. 64
    Stephen G. Reich, Palliative Medicine, 2009,

    CrossRef

  65. 65
    Kurt A. Jellinger, A critical reappraisal of current staging of Lewy-related pathology in human brain, Acta Neuropathologica, 2008, 116, 1, 1

    CrossRef

  66. 66
    K. A. Jellinger, J. Attems, Cerebral amyloid angiopathy in Lewy body disease, Journal of Neural Transmission, 2008, 115, 3, 473

    CrossRef

  67. 67
    Lucilla Parnetti, Pietro Tiraboschi, Alessia Lanari, Maria Peducci, Chiara Padiglioni, Cataldo D'Amore, Laura Pierguidi, Nicola Tambasco, Aroldo Rossi, Paolo Calabresi, Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies, Biological Psychiatry, 2008, 64, 10, 850

    CrossRef

  68. 68
    K. Markopoulou, D. W. Dickson, R. D. McComb, Z. K. Wszolek, L. Katechalidou, L. Avery, M. S. Stansbury, B. A. Chase, Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease, Acta Neuropathologica, 2008, 116, 1, 25

    CrossRef

  69. 69
    Michael J. Devine, Patrick A. Lewis, Emerging pathways in genetic Parkinson’s disease: tangles, Lewy bodies and LRRK2, FEBS Journal, 2008, 275, 23
  70. 70
    Katja Lohmann, Christine Klein, GENETICS OF PARKINSON DISEASE, CONTINUUM: Lifelong Learning in Neurology, 2008, 14, 90

    CrossRef

  71. 71
    Terhi Peuralinna, Minna Oinas, Tuomo Polvikoski, Anders Paetau, Raimo Sulkava, Leena Niinistö, Hannu Kalimo, Dena Hernandez, John Hardy, Andrew Singleton, Pentti J. Tienari, Liisa Myllykangas, Neurofibrillary tau pathology modulated by genetic variation of α-synuclein, Annals of Neurology, 2008, 64, 3
  72. 72
    Kurt A. Jellinger, Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia, Neurodegenerative Diseases, 2008, 5, 3-4, 118

    CrossRef

  73. 73
    L. F. Agnati, E. Baldelli, N. Andreoli, A. S. Woods, V. Vellani, D. Marcellino, D. Guidolin, K. Fuxe, On the key role played by altered protein conformation in Parkinson’s disease, Journal of Neural Transmission, 2008, 115, 9, 1285

    CrossRef

  74. 74
    G. Muntané, E. Dalfó, A. Martinez, I. Ferrer, Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies, Neuroscience, 2008, 152, 4, 913

    CrossRef

  75. 75
    Kurt A. Jellinger, Johannes Attems, Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease, Acta Neuropathologica, 2008, 115, 4, 427

    CrossRef

  76. 76
    Michail E. Kalaitzakis, Manuel B. Graeber, Stephen M. Gentleman, Ronald K. B. Pearce, Striatal β-Amyloid Deposition in Parkinson Disease With Dementia, Journal of Neuropathology and Experimental Neurology, 2008, 67, 2, 155

    CrossRef

  77. 77
    Patrick L. McGeer, Edith G. McGeer, The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease, Experimental Neurology, 2008, 212, 2, 235

    CrossRef

  78. 78
    Richard A Armstrong, Visual signs and symptoms of Parkinson's disease, Clinical and Experimental Optometry, 2008, 91, 2
  79. You have free access to this content79
    Richard A. Armstrong, Peter L. Lantos, Nigel J. Cairns, What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?, Neuropathology, 2008, 28, 4
  80. 80
    X. William Yang, Xiao-Hong Lu, Parkinson's Disease, 2008,

    CrossRef

  81. 81
    Mark G. Hickey, Bart M. Demaerschalk, Richard J. Caselli, James M. Parish, Dean M. Wingerchuk, ???Idiopathic??? Rapid-Eye-Movement (REM) Sleep Behavior Disorder Is Associated With Future Development of Neurodegenerative Diseases, The Neurologist, 2007, 13, 2, 98

    CrossRef

  82. 82
    Susan Fox, Anthony Lang, An update on movement disorders: exciting developments but new obstacles, Current Opinion in Neurology, 2007, 20, 4, 432

    CrossRef

  83. 83
    Cyrus P. Zabetian, Carolyn M. Hutter, Stewart A. Factor, John G. Nutt, Donald S. Higgins, Alida Griffith, John W. Roberts, Berta C. Leis, Denise M. Kay, Dora Yearout, Jennifer S. Montimurro, Karen L. Edwards, Ali Samii, Haydeh Payami, Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease, Annals of Neurology, 2007, 62, 2
  84. 84
    R. Rusina, F. Bourdain, R. Matěj, Atrophie multi-systématisée et maladie d́Alzheimer : association rare de deux affections neuro-dégénératives. À propos d’un cas, Revue Neurologique, 2007, 163, 12, 1239

    CrossRef

  85. 85
    Christine Klein, Katja Lohmann-Hedrich, Ekaterina Rogaeva, Michael G Schlossmacher, Anthony E Lang, Deciphering the role of heterozygous mutations in genes associated with parkinsonism, The Lancet Neurology, 2007, 6, 7, 652

    CrossRef

  86. 86
    Ravindran Kumaran, Ann Kingsbury, Ian Coulter, Tammaryn Lashley, David Williams, Rohan de Silva, David Mann, Tamas Revesz, Andrew Lees, Rina Bandopadhyay, DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders, Neurobiology of Disease, 2007, 28, 1, 122

    CrossRef

  87. 87
    Christine Klein, Katja Lohmann-Hedrich, Impact of recent genetic findings in Parkinson??s disease, Current Opinion in Neurology, 2007, 20, 4, 453

    CrossRef

  88. 88
    Vladimir N. Uversky, Neuropathology, biochemistry, and biophysics of α-synuclein aggregation, Journal of Neurochemistry, 2007, 103, 1
  89. 89
    Spiridon Papapetropoulos, Matthew J. Farrer, Jeremy T. Stone, Nicole M. Milkovic, Owen A. Ross, Linda Calvo, Donald McQuorquodale, Deborah C. Mash, Phenotypic associations of tau and ApoE in Parkinson's disease, Neuroscience Letters, 2007, 414, 2, 141

    CrossRef

  90. 90
    An Goris, Caroline H. Williams-Gray, Graeme R. Clark, Thomas Foltynie, Simon J. G. Lewis, Joanne Brown, Maria Ban, Maria G. Spillantini, Alastair Compston, David J. Burn, Patrick F. Chinnery, Roger A. Barker, Stephen J. Sawcer, Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease, Annals of Neurology, 2007, 62, 2
  91. 91
    Koichi Wakabayashi, Kunikazu Tanji, Fumiaki Mori, Hitoshi Takahashi, The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α-synuclein aggregates, Neuropathology, 2007, 27, 5
  92. 92
    Kurt A. Jellinger, Johannes Attems, Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?, Acta Neuropathologica, 2006, 112, 3, 253

    CrossRef

  93. 93
    Kurt A. Jellinger, P25α immunoreactivity in multiple system atrophy and Parkinson disease, Acta Neuropathologica, 2006, 112, 1, 112

    CrossRef

  94. 94
    Kristoffer Haugarvoll, Zbigniew K. Wszolek, PARK8 LRRK2 parkinsonism, Current Neurology and Neuroscience Reports, 2006, 6, 4, 287

    CrossRef

  95. 95
    Tetsutaro Ozawa, Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum, Acta Neuropathologica, 2006, 112, 5, 531

    CrossRef

  96. 96
    Johannes Attems, Magdalena Quass, Kurt A. Jellinger, Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs, Acta Neuropathologica, 2006, 113, 1, 53

    CrossRef

  97. 97
    Vladimir N. Uversky, Intrinsically Disordered Chaperones and Neurodegeneration,